Viewing Study NCT06225856


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2025-12-25 @ 9:15 PM
Study NCT ID: NCT06225856
Status: RECRUITING
Last Update Posted: 2024-01-31
First Post: 2024-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
Sponsor: Shanghai Yuyao Biotech Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-10-26
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-17
First Submit QC Date: None
Study First Post Date: 2024-01-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-29
Last Update Post Date: 2024-01-31
Last Update Post Date Type: ACTUAL